iShares U.S. Healthcare ETF News - September 11, 2026

Novo Nordisk wins China approval for Wegovy, first GLP-1 for liver disease

Novo Nordisk announced Thursday that Chinese regulators approved its drug Wegovy for a new indication. The approval covers the treatment of metabolic...